Flu Vaccine-2004-2005 Vaccine Shortage
Americans have faced flu vaccine shortage on multiple occasions. The demand for the vaccine outstripped supply when problems developing a new strain and safety and quality control issues delayed the vaccine delivery. In 2004-2005, two companies produced all the flu vaccine for the United States. Aventis and Chiron hoped to provide 100 million doses for the 2004-2005 flu seasons, but liked in recent years Americans have faced flu vaccine shortages on multiple occasions. By august 26, 2004, President Bush Administration announced and guarantied available flu vaccine. In august 27, 2014, one of the suppliers, Chiron announced contamination of 38 million doses of flu vaccine (nearly half the U.S. supply). On October 2004, Chiron's license was suspended and the plant is closed. The U.S. government had no idea that the contamination was a major problem at the supply plant. The government’s actions were to investigate, set priority on high risk area, started to search for additional vaccines supply, and imported costly flu shots. II.
a. Vaccine Production
Plants take time to set up
Is time consuming
High long-term production cost
b. Public Administration System
High FDA standards
c. Flu Vaccine Crisis
Public health threat
Vaccine smuggling and theft
Movement to Canada for flu vaccine shots
Government crisis response
CDC recommended that vaccines be reserved for high risk patients •
A flu vaccine task force was established to help manage the distribution and price control •
Delayed supplies let to excess unutilized stock of vaccines IV.
1. Close cooperation with other countries
2. Review FDA approval/quality assurance procedures to ensure timeline without compromising...
Please join StudyMode to read the full document